PI
NVO

PEAK6 Investments’s Novo Nordisk NVO Stock Holding History

PEAK6 Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.19M Sell
10,000
-77,000
-89% -$10.3M ﹤0.01% 1801
2024
Q2 		$12.4M Sell
87,000
-77,100
-47% -$10.2M 0.03% 419
2024
Q1 		$21.1M Buy
164,100
+144,300
+729% +$17.2M 0.06% 276
2023
Q4 		$2.05M Buy
19,800
+3,600
+22% +$356K 0.01% 1500
2023
Q3 		$1.47M Sell
16,200
-40,600
-71% -$3.58M 0.01% 1549
2023
Q2 		$4.6M Sell
56,800
-4,000
-7% -$327K 0.02% 694
2023
Q1 		$4.84M Sell
60,800
-378,800
-86% -$26.9M 0.02% 719
2022
Q4 		$29.7M Buy
439,600
+428,800
+3,970% +$25.1M 0.17% 99
2022
Q3 		$538K Sell
10,800
-51,400
-83% -$2.75M ﹤0.01% 2795
2022
Q2 		$4.9M Buy
62,200
+2,200
+4% +$122K 0.01% 1396
2022
Q1 		$3.33M Buy
+60,000
New +$3.08M 0.01% 1408
2021
Q4 		– Sell
-19,000
Closed -$912K – 5596
2021
Q3 		$912K Buy
+19,000
New +$919K ﹤0.01% 2699
2021
Q1 		– Sell
-261,200
Closed -$9.12M – 5337
2020
Q4 		$9.12M Sell
261,200
-310,000
-54% -$10.7M 0.02% 719
2020
Q3 		$19.8M Buy
571,200
+3,600
+0.6% +$120K 0.05% 335
2020
Q2 		$18.6M Buy
567,600
+371,200
+189% +$11.8M 0.06% 274
2020
Q1 		$5.91M Buy
+196,400
New +$5.85M 0.03% 475
2019
Q4 		– Sell
-22,200
Closed -$574K – 3842
2019
Q3 		$574K Buy
+22,200
New +$561K ﹤0.01% 2176
2019
Q1 		– Sell
-25,000
Closed -$576K – 4408
2018
Q4 		$576K Hold
25,000
– – ﹤0.01% 2232
2018
Q3 		$589K Buy
+25,000
New +$610K ﹤0.01% 2428

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PEAK6 Investments's NVO Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Novo Nordisk (NVO) in Q3 2024: 66,149 shares worth $7.88M. The stake represents 0.02% of the portfolio and ranks #690 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in NVO as recently as Q3 2023.

PEAK6 Investments first reported a position in NVO in Q1 2019 and has held it in 12 quarters since. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • PEAK6 Investments held 66,149 shares of Novo Nordisk worth $7.88M as of Q3 2024.
  • Novo Nordisk was a new PEAK6 Investments position in Q3 2024.
  • Novo Nordisk made up 0.02% of PEAK6 Investments's portfolio in Q3 2024, its #690 holding.
  • PEAK6 Investments first reported a position in Novo Nordisk in Q1 2019 and has held it in 12 quarters since.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.